サマリー

鼻アレルギー治療の世界市場規模は、2022年の6456.5百万米ドルから2029年には10550百万米ドルに成長すると予測され、2023年から2029年までのCAGRは7.3％と予測されています。
鼻アレルギー治療薬の米国市場は、2023年から2029年までのCAGRで、2022年の100万米ドルから2029年には100万米ドルに増加すると予測されています。
鼻アレルギー治療の中国市場は、2023年から2029年にかけてのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
鼻アレルギー治療のヨーロッパ市場は、2023年から2029年にかけてのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
鼻アレルギー治療の世界主要企業は、Bayer、Novartis International AG、Meda Pharmaceuticals, Inc、Bausch Health Companies Inc.、Allergopharma、ALK Abello、Stallergenes Greer、Allergy Therapeutics、Aimmune Therapeuticsなど。収益面では、世界の2大企業が2022年にほぼ％のシェアを占めています。
アレルギー性鼻炎は、花粉、ほこり、カビ、特定の動物の皮膚片などのアレルゲンによって引き起こされる鼻の内側の炎症です。他の薬と一緒に服用する充血除去剤点鼻薬の短期コースを使用します。
LPI（エルピーアイ）の最新リサーチレポート「鼻アレルギー治療薬の業界予測」は、過去の販売実績から2022年の世界の鼻アレルギー治療薬の総販売実績を検証し、2023年から2029年の鼻アレルギー治療薬の販売予測について地域や市場分野ごとに包括的な分析を提供しています。鼻アレルギー治療薬の売上を地域別、市場分野別、サブセクター別に分類し、世界の鼻アレルギー治療薬産業の詳細な分析を百万米ドル単位で提供します。
本インサイトレポートでは、世界の鼻アレルギー治療の状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにしています。また、本レポートでは、鼻アレルギー治療のポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当てて、主要グローバル企業の戦略を分析し、加速する世界の鼻アレルギー治療市場におけるこれらの企業の独自のポジションをよりよく理解することができます。
本インサイトレポートでは、鼻アレルギー治療薬の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、この調査予測は、世界の鼻アレルギー治療における現状と将来の軌道について非常にニュアンスのある見解を提供します。
本レポートでは、鼻アレルギー治療市場の製品タイプ、用途、主要メーカー、主要地域、国別の包括的な概要、市場シェア、成長機会について紹介します。
市場のセグメンテーション
タイプ別セグメンテーション
一般用医薬品
処方箋
用途別セグメンテーション
病院薬局
オンライン薬局
小売薬局
また、本レポートでは、地域別に市場を分割しています：
米州
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
中近東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した上で選定されています。
バイエル
ノバルティスインターナショナルAG
メダ・ファーマシューティカルズ・インク
ボシュ・ヘルス・カンパニーズ・インク
アレルゴファーマ
アルクアベロ
ストールゲネス・グリア
アレルギ-セラピューティクス
アイミューン セラピューティクス
バイオメイAG
HAL アレルギーグループ
アストラゼネカ
メルクKGaA
ジョンソン・エンド・ジョンソン
サノフィSA
アレルファーマS.A
ジェネンテック・インク
グラクソ・スミスクラインPLC
アラガン社（Allergan, Inc.
レティ・ファーマ
本レポートで取り上げる主な質問
鼻アレルギー治療薬の世界市場の10年後の展望は？
世界および地域別に、鼻腔アレルギー治療薬市場の成長を促進する要因は何か？
市場別、地域別に最も急成長を遂げる技術は何か？
鼻アレルギー治療の市場機会はエンドマーケットの規模によってどのように変化するか？
鼻アレルギー治療薬のタイプ別、用途別の内訳は？
COVID-19とロシア・ウクライナ戦争の影響とは？

ページTOPに戻る

目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nasal Allergy Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Nasal Allergy Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Nasal Allergy Treatment by Country/Region, 2018, 2022 & 2029
2.2 Nasal Allergy Treatment Segment by Type
2.2.1 OTC
2.2.2 Prescription
2.3 Nasal Allergy Treatment Sales by Type
2.3.1 Global Nasal Allergy Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Nasal Allergy Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Nasal Allergy Treatment Sale Price by Type (2018-2023)
2.4 Nasal Allergy Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Online Pharmacies
2.4.3 Retail Pharmacies
2.5 Nasal Allergy Treatment Sales by Application
2.5.1 Global Nasal Allergy Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Nasal Allergy Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Nasal Allergy Treatment Sale Price by Application (2018-2023)
3 Global Nasal Allergy Treatment by Company
3.1 Global Nasal Allergy Treatment Breakdown Data by Company
3.1.1 Global Nasal Allergy Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Nasal Allergy Treatment Sales Market Share by Company (2018-2023)
3.2 Global Nasal Allergy Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Nasal Allergy Treatment Revenue by Company (2018-2023)
3.2.2 Global Nasal Allergy Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Nasal Allergy Treatment Sale Price by Company
3.4 Key Manufacturers Nasal Allergy Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nasal Allergy Treatment Product Location Distribution
3.4.2 Players Nasal Allergy Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nasal Allergy Treatment by Geographic Region
4.1 World Historic Nasal Allergy Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Nasal Allergy Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Nasal Allergy Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nasal Allergy Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Nasal Allergy Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Nasal Allergy Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nasal Allergy Treatment Sales Growth
4.4 APAC Nasal Allergy Treatment Sales Growth
4.5 Europe Nasal Allergy Treatment Sales Growth
4.6 Middle East & Africa Nasal Allergy Treatment Sales Growth
5 Americas
5.1 Americas Nasal Allergy Treatment Sales by Country
5.1.1 Americas Nasal Allergy Treatment Sales by Country (2018-2023)
5.1.2 Americas Nasal Allergy Treatment Revenue by Country (2018-2023)
5.2 Americas Nasal Allergy Treatment Sales by Type
5.3 Americas Nasal Allergy Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nasal Allergy Treatment Sales by Region
6.1.1 APAC Nasal Allergy Treatment Sales by Region (2018-2023)
6.1.2 APAC Nasal Allergy Treatment Revenue by Region (2018-2023)
6.2 APAC Nasal Allergy Treatment Sales by Type
6.3 APAC Nasal Allergy Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nasal Allergy Treatment by Country
7.1.1 Europe Nasal Allergy Treatment Sales by Country (2018-2023)
7.1.2 Europe Nasal Allergy Treatment Revenue by Country (2018-2023)
7.2 Europe Nasal Allergy Treatment Sales by Type
7.3 Europe Nasal Allergy Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nasal Allergy Treatment by Country
8.1.1 Middle East & Africa Nasal Allergy Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Nasal Allergy Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Nasal Allergy Treatment Sales by Type
8.3 Middle East & Africa Nasal Allergy Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nasal Allergy Treatment
10.3 Manufacturing Process Analysis of Nasal Allergy Treatment
10.4 Industry Chain Structure of Nasal Allergy Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nasal Allergy Treatment Distributors
11.3 Nasal Allergy Treatment Customer
12 World Forecast Review for Nasal Allergy Treatment by Geographic Region
12.1 Global Nasal Allergy Treatment Market Size Forecast by Region
12.1.1 Global Nasal Allergy Treatment Forecast by Region (2024-2029)
12.1.2 Global Nasal Allergy Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nasal Allergy Treatment Forecast by Type
12.7 Global Nasal Allergy Treatment Forecast by Application
13 Key Players Analysis
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Nasal Allergy Treatment Product Portfolios and Specifications
13.1.3 Bayer Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Novartis International AG
13.2.1 Novartis International AG Company Information
13.2.2 Novartis International AG Nasal Allergy Treatment Product Portfolios and Specifications
13.2.3 Novartis International AG Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novartis International AG Main Business Overview
13.2.5 Novartis International AG Latest Developments
13.3 Meda Pharmaceuticals, Inc
13.3.1 Meda Pharmaceuticals, Inc Company Information
13.3.2 Meda Pharmaceuticals, Inc Nasal Allergy Treatment Product Portfolios and Specifications
13.3.3 Meda Pharmaceuticals, Inc Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Meda Pharmaceuticals, Inc Main Business Overview
13.3.5 Meda Pharmaceuticals, Inc Latest Developments
13.4 Bausch Health Companies Inc.
13.4.1 Bausch Health Companies Inc. Company Information
13.4.2 Bausch Health Companies Inc. Nasal Allergy Treatment Product Portfolios and Specifications
13.4.3 Bausch Health Companies Inc. Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bausch Health Companies Inc. Main Business Overview
13.4.5 Bausch Health Companies Inc. Latest Developments
13.5 Allergopharma
13.5.1 Allergopharma Company Information
13.5.2 Allergopharma Nasal Allergy Treatment Product Portfolios and Specifications
13.5.3 Allergopharma Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Allergopharma Main Business Overview
13.5.5 Allergopharma Latest Developments
13.6 ALK Abello
13.6.1 ALK Abello Company Information
13.6.2 ALK Abello Nasal Allergy Treatment Product Portfolios and Specifications
13.6.3 ALK Abello Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 ALK Abello Main Business Overview
13.6.5 ALK Abello Latest Developments
13.7 Stallergenes Greer
13.7.1 Stallergenes Greer Company Information
13.7.2 Stallergenes Greer Nasal Allergy Treatment Product Portfolios and Specifications
13.7.3 Stallergenes Greer Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Stallergenes Greer Main Business Overview
13.7.5 Stallergenes Greer Latest Developments
13.8 Allergy Therapeutics
13.8.1 Allergy Therapeutics Company Information
13.8.2 Allergy Therapeutics Nasal Allergy Treatment Product Portfolios and Specifications
13.8.3 Allergy Therapeutics Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Allergy Therapeutics Main Business Overview
13.8.5 Allergy Therapeutics Latest Developments
13.9 Aimmune Therapeutics
13.9.1 Aimmune Therapeutics Company Information
13.9.2 Aimmune Therapeutics Nasal Allergy Treatment Product Portfolios and Specifications
13.9.3 Aimmune Therapeutics Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Aimmune Therapeutics Main Business Overview
13.9.5 Aimmune Therapeutics Latest Developments
13.10 Biomay AG
13.10.1 Biomay AG Company Information
13.10.2 Biomay AG Nasal Allergy Treatment Product Portfolios and Specifications
13.10.3 Biomay AG Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Biomay AG Main Business Overview
13.10.5 Biomay AG Latest Developments
13.11 HAL Allergy Group
13.11.1 HAL Allergy Group Company Information
13.11.2 HAL Allergy Group Nasal Allergy Treatment Product Portfolios and Specifications
13.11.3 HAL Allergy Group Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 HAL Allergy Group Main Business Overview
13.11.5 HAL Allergy Group Latest Developments
13.12 AstraZeneca
13.12.1 AstraZeneca Company Information
13.12.2 AstraZeneca Nasal Allergy Treatment Product Portfolios and Specifications
13.12.3 AstraZeneca Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 AstraZeneca Main Business Overview
13.12.5 AstraZeneca Latest Developments
13.13 Merck KGaA
13.13.1 Merck KGaA Company Information
13.13.2 Merck KGaA Nasal Allergy Treatment Product Portfolios and Specifications
13.13.3 Merck KGaA Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Merck KGaA Main Business Overview
13.13.5 Merck KGaA Latest Developments
13.14 Johnson & Johnson
13.14.1 Johnson & Johnson Company Information
13.14.2 Johnson & Johnson Nasal Allergy Treatment Product Portfolios and Specifications
13.14.3 Johnson & Johnson Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Johnson & Johnson Main Business Overview
13.14.5 Johnson & Johnson Latest Developments
13.15 Sanofi SA
13.15.1 Sanofi SA Company Information
13.15.2 Sanofi SA Nasal Allergy Treatment Product Portfolios and Specifications
13.15.3 Sanofi SA Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Sanofi SA Main Business Overview
13.15.5 Sanofi SA Latest Developments
13.16 Alerpharma S.A
13.16.1 Alerpharma S.A Company Information
13.16.2 Alerpharma S.A Nasal Allergy Treatment Product Portfolios and Specifications
13.16.3 Alerpharma S.A Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Alerpharma S.A Main Business Overview
13.16.5 Alerpharma S.A Latest Developments
13.17 Genentech Inc.
13.17.1 Genentech Inc. Company Information
13.17.2 Genentech Inc. Nasal Allergy Treatment Product Portfolios and Specifications
13.17.3 Genentech Inc. Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Genentech Inc. Main Business Overview
13.17.5 Genentech Inc. Latest Developments
13.18 GlaxoSmithKline PLC
13.18.1 GlaxoSmithKline PLC Company Information
13.18.2 GlaxoSmithKline PLC Nasal Allergy Treatment Product Portfolios and Specifications
13.18.3 GlaxoSmithKline PLC Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 GlaxoSmithKline PLC Main Business Overview
13.18.5 GlaxoSmithKline PLC Latest Developments
13.19 Allergan, Inc.
13.19.1 Allergan, Inc. Company Information
13.19.2 Allergan, Inc. Nasal Allergy Treatment Product Portfolios and Specifications
13.19.3 Allergan, Inc. Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Allergan, Inc. Main Business Overview
13.19.5 Allergan, Inc. Latest Developments
13.20 Leti Pharma
13.20.1 Leti Pharma Company Information
13.20.2 Leti Pharma Nasal Allergy Treatment Product Portfolios and Specifications
13.20.3 Leti Pharma Nasal Allergy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Leti Pharma Main Business Overview
13.20.5 Leti Pharma Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

図表リスト

List of Tables
Table 1. Nasal Allergy Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Nasal Allergy Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of OTC
Table 4. Major Players of Prescription
Table 5. Global Nasal Allergy Treatment Sales by Type (2018-2023) & (K Units)
Table 6. Global Nasal Allergy Treatment Sales Market Share by Type (2018-2023)
Table 7. Global Nasal Allergy Treatment Revenue by Type (2018-2023) & ($ million)
Table 8. Global Nasal Allergy Treatment Revenue Market Share by Type (2018-2023)
Table 9. Global Nasal Allergy Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Nasal Allergy Treatment Sales by Application (2018-2023) & (K Units)
Table 11. Global Nasal Allergy Treatment Sales Market Share by Application (2018-2023)
Table 12. Global Nasal Allergy Treatment Revenue by Application (2018-2023)
Table 13. Global Nasal Allergy Treatment Revenue Market Share by Application (2018-2023)
Table 14. Global Nasal Allergy Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Nasal Allergy Treatment Sales by Company (2018-2023) & (K Units)
Table 16. Global Nasal Allergy Treatment Sales Market Share by Company (2018-2023)
Table 17. Global Nasal Allergy Treatment Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Nasal Allergy Treatment Revenue Market Share by Company (2018-2023)
Table 19. Global Nasal Allergy Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Nasal Allergy Treatment Producing Area Distribution and Sales Area
Table 21. Players Nasal Allergy Treatment Products Offered
Table 22. Nasal Allergy Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nasal Allergy Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Nasal Allergy Treatment Sales Market Share Geographic Region (2018-2023)
Table 27. Global Nasal Allergy Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Nasal Allergy Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Nasal Allergy Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Nasal Allergy Treatment Sales Market Share by Country/Region (2018-2023)
Table 31. Global Nasal Allergy Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Nasal Allergy Treatment Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Nasal Allergy Treatment Sales by Country (2018-2023) & (K Units)
Table 34. Americas Nasal Allergy Treatment Sales Market Share by Country (2018-2023)
Table 35. Americas Nasal Allergy Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Nasal Allergy Treatment Revenue Market Share by Country (2018-2023)
Table 37. Americas Nasal Allergy Treatment Sales by Type (2018-2023) & (K Units)
Table 38. Americas Nasal Allergy Treatment Sales by Application (2018-2023) & (K Units)
Table 39. APAC Nasal Allergy Treatment Sales by Region (2018-2023) & (K Units)
Table 40. APAC Nasal Allergy Treatment Sales Market Share by Region (2018-2023)
Table 41. APAC Nasal Allergy Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Nasal Allergy Treatment Revenue Market Share by Region (2018-2023)
Table 43. APAC Nasal Allergy Treatment Sales by Type (2018-2023) & (K Units)
Table 44. APAC Nasal Allergy Treatment Sales by Application (2018-2023) & (K Units)
Table 45. Europe Nasal Allergy Treatment Sales by Country (2018-2023) & (K Units)
Table 46. Europe Nasal Allergy Treatment Sales Market Share by Country (2018-2023)
Table 47. Europe Nasal Allergy Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Nasal Allergy Treatment Revenue Market Share by Country (2018-2023)
Table 49. Europe Nasal Allergy Treatment Sales by Type (2018-2023) & (K Units)
Table 50. Europe Nasal Allergy Treatment Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Nasal Allergy Treatment Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Nasal Allergy Treatment Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Nasal Allergy Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Nasal Allergy Treatment Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Nasal Allergy Treatment Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Nasal Allergy Treatment Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Nasal Allergy Treatment
Table 58. Key Market Challenges & Risks of Nasal Allergy Treatment
Table 59. Key Industry Trends of Nasal Allergy Treatment
Table 60. Nasal Allergy Treatment Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Nasal Allergy Treatment Distributors List
Table 63. Nasal Allergy Treatment Customer List
Table 64. Global Nasal Allergy Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Nasal Allergy Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Nasal Allergy Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Nasal Allergy Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Nasal Allergy Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Nasal Allergy Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Nasal Allergy Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Nasal Allergy Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Nasal Allergy Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Nasal Allergy Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Nasal Allergy Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Nasal Allergy Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Nasal Allergy Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Nasal Allergy Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Bayer Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 79. Bayer Nasal Allergy Treatment Product Portfolios and Specifications
Table 80. Bayer Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Bayer Main Business
Table 82. Bayer Latest Developments
Table 83. Novartis International AG Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 84. Novartis International AG Nasal Allergy Treatment Product Portfolios and Specifications
Table 85. Novartis International AG Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Novartis International AG Main Business
Table 87. Novartis International AG Latest Developments
Table 88. Meda Pharmaceuticals, Inc Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 89. Meda Pharmaceuticals, Inc Nasal Allergy Treatment Product Portfolios and Specifications
Table 90. Meda Pharmaceuticals, Inc Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Meda Pharmaceuticals, Inc Main Business
Table 92. Meda Pharmaceuticals, Inc Latest Developments
Table 93. Bausch Health Companies Inc. Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 94. Bausch Health Companies Inc. Nasal Allergy Treatment Product Portfolios and Specifications
Table 95. Bausch Health Companies Inc. Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Bausch Health Companies Inc. Main Business
Table 97. Bausch Health Companies Inc. Latest Developments
Table 98. Allergopharma Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 99. Allergopharma Nasal Allergy Treatment Product Portfolios and Specifications
Table 100. Allergopharma Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Allergopharma Main Business
Table 102. Allergopharma Latest Developments
Table 103. ALK Abello Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 104. ALK Abello Nasal Allergy Treatment Product Portfolios and Specifications
Table 105. ALK Abello Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. ALK Abello Main Business
Table 107. ALK Abello Latest Developments
Table 108. Stallergenes Greer Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 109. Stallergenes Greer Nasal Allergy Treatment Product Portfolios and Specifications
Table 110. Stallergenes Greer Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Stallergenes Greer Main Business
Table 112. Stallergenes Greer Latest Developments
Table 113. Allergy Therapeutics Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 114. Allergy Therapeutics Nasal Allergy Treatment Product Portfolios and Specifications
Table 115. Allergy Therapeutics Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Allergy Therapeutics Main Business
Table 117. Allergy Therapeutics Latest Developments
Table 118. Aimmune Therapeutics Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 119. Aimmune Therapeutics Nasal Allergy Treatment Product Portfolios and Specifications
Table 120. Aimmune Therapeutics Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Aimmune Therapeutics Main Business
Table 122. Aimmune Therapeutics Latest Developments
Table 123. Biomay AG Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 124. Biomay AG Nasal Allergy Treatment Product Portfolios and Specifications
Table 125. Biomay AG Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Biomay AG Main Business
Table 127. Biomay AG Latest Developments
Table 128. HAL Allergy Group Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 129. HAL Allergy Group Nasal Allergy Treatment Product Portfolios and Specifications
Table 130. HAL Allergy Group Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. HAL Allergy Group Main Business
Table 132. HAL Allergy Group Latest Developments
Table 133. AstraZeneca Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 134. AstraZeneca Nasal Allergy Treatment Product Portfolios and Specifications
Table 135. AstraZeneca Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. AstraZeneca Main Business
Table 137. AstraZeneca Latest Developments
Table 138. Merck KGaA Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 139. Merck KGaA Nasal Allergy Treatment Product Portfolios and Specifications
Table 140. Merck KGaA Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Merck KGaA Main Business
Table 142. Merck KGaA Latest Developments
Table 143. Johnson & Johnson Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 144. Johnson & Johnson Nasal Allergy Treatment Product Portfolios and Specifications
Table 145. Johnson & Johnson Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Johnson & Johnson Main Business
Table 147. Johnson & Johnson Latest Developments
Table 148. Sanofi SA Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 149. Sanofi SA Nasal Allergy Treatment Product Portfolios and Specifications
Table 150. Sanofi SA Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Sanofi SA Main Business
Table 152. Sanofi SA Latest Developments
Table 153. Alerpharma S.A Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 154. Alerpharma S.A Nasal Allergy Treatment Product Portfolios and Specifications
Table 155. Alerpharma S.A Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Alerpharma S.A Main Business
Table 157. Alerpharma S.A Latest Developments
Table 158. Genentech Inc. Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 159. Genentech Inc. Nasal Allergy Treatment Product Portfolios and Specifications
Table 160. Genentech Inc. Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Genentech Inc. Main Business
Table 162. Genentech Inc. Latest Developments
Table 163. GlaxoSmithKline PLC Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 164. GlaxoSmithKline PLC Nasal Allergy Treatment Product Portfolios and Specifications
Table 165. GlaxoSmithKline PLC Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. GlaxoSmithKline PLC Main Business
Table 167. GlaxoSmithKline PLC Latest Developments
Table 168. Allergan, Inc. Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 169. Allergan, Inc. Nasal Allergy Treatment Product Portfolios and Specifications
Table 170. Allergan, Inc. Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Allergan, Inc. Main Business
Table 172. Allergan, Inc. Latest Developments
Table 173. Leti Pharma Basic Information, Nasal Allergy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 174. Leti Pharma Nasal Allergy Treatment Product Portfolios and Specifications
Table 175. Leti Pharma Nasal Allergy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Leti Pharma Main Business
Table 177. Leti Pharma Latest Developments
List of Figures
Figure 1. Picture of Nasal Allergy Treatment
Figure 2. Nasal Allergy Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nasal Allergy Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Nasal Allergy Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Nasal Allergy Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of OTC
Figure 10. Product Picture of Prescription
Figure 11. Global Nasal Allergy Treatment Sales Market Share by Type in 2022
Figure 12. Global Nasal Allergy Treatment Revenue Market Share by Type (2018-2023)
Figure 13. Nasal Allergy Treatment Consumed in Hospital Pharmacies
Figure 14. Global Nasal Allergy Treatment Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 15. Nasal Allergy Treatment Consumed in Online Pharmacies
Figure 16. Global Nasal Allergy Treatment Market: Online Pharmacies (2018-2023) & (K Units)
Figure 17. Nasal Allergy Treatment Consumed in Retail Pharmacies
Figure 18. Global Nasal Allergy Treatment Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 19. Global Nasal Allergy Treatment Sales Market Share by Application (2022)
Figure 20. Global Nasal Allergy Treatment Revenue Market Share by Application in 2022
Figure 21. Nasal Allergy Treatment Sales Market by Company in 2022 (K Units)
Figure 22. Global Nasal Allergy Treatment Sales Market Share by Company in 2022
Figure 23. Nasal Allergy Treatment Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Nasal Allergy Treatment Revenue Market Share by Company in 2022
Figure 25. Global Nasal Allergy Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Nasal Allergy Treatment Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Nasal Allergy Treatment Sales 2018-2023 (K Units)
Figure 28. Americas Nasal Allergy Treatment Revenue 2018-2023 ($ Millions)
Figure 29. APAC Nasal Allergy Treatment Sales 2018-2023 (K Units)
Figure 30. APAC Nasal Allergy Treatment Revenue 2018-2023 ($ Millions)
Figure 31. Europe Nasal Allergy Treatment Sales 2018-2023 (K Units)
Figure 32. Europe Nasal Allergy Treatment Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Nasal Allergy Treatment Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Nasal Allergy Treatment Revenue 2018-2023 ($ Millions)
Figure 35. Americas Nasal Allergy Treatment Sales Market Share by Country in 2022
Figure 36. Americas Nasal Allergy Treatment Revenue Market Share by Country in 2022
Figure 37. Americas Nasal Allergy Treatment Sales Market Share by Type (2018-2023)
Figure 38. Americas Nasal Allergy Treatment Sales Market Share by Application (2018-2023)
Figure 39. United States Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Nasal Allergy Treatment Sales Market Share by Region in 2022
Figure 44. APAC Nasal Allergy Treatment Revenue Market Share by Regions in 2022
Figure 45. APAC Nasal Allergy Treatment Sales Market Share by Type (2018-2023)
Figure 46. APAC Nasal Allergy Treatment Sales Market Share by Application (2018-2023)
Figure 47. China Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Nasal Allergy Treatment Sales Market Share by Country in 2022
Figure 55. Europe Nasal Allergy Treatment Revenue Market Share by Country in 2022
Figure 56. Europe Nasal Allergy Treatment Sales Market Share by Type (2018-2023)
Figure 57. Europe Nasal Allergy Treatment Sales Market Share by Application (2018-2023)
Figure 58. Germany Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Nasal Allergy Treatment Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Nasal Allergy Treatment Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Nasal Allergy Treatment Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Nasal Allergy Treatment Sales Market Share by Application (2018-2023)
Figure 67. Egypt Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Nasal Allergy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Nasal Allergy Treatment in 2022
Figure 73. Manufacturing Process Analysis of Nasal Allergy Treatment
Figure 74. Industry Chain Structure of Nasal Allergy Treatment
Figure 75. Channels of Distribution
Figure 76. Global Nasal Allergy Treatment Sales Market Forecast by Region (2024-2029)
Figure 77. Global Nasal Allergy Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Nasal Allergy Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Nasal Allergy Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Nasal Allergy Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Nasal Allergy Treatment Revenue Market Share Forecast by Application (2024-2029)